During the past decade, Hospital de Torrevieja conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Torrevieja" #1 sponsor was "SOLTI Breast Cancer Research Group" with 2 trials, followed by "Spanish Lung Cancer Group" with 2 trials sponsored, "Advancell - Advanced In Vitro Cell Technologies, S.A." with 1 trials sponsored, "Bioithas SL" with 1 trials sponsored and "Biopolis S.L." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Torrevieja" #1 collaborator was "Biopolis S.L." with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cromsource" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Torrevieja" are "Breast Cancer" (4 trials), "Lung Cancer" (2 trials), "Acute Respiratory Failure" (1 trials), "Alzheimer Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hospital de Torrevieja" in a lesser frequency.

Most popular intervention types in "Hospital de Torrevieja" are "Drug" (12 trials), "Device" (3 trials), "Dietary Supplement" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "1 drop of 0.375% SYL040012 (bamosiran)" (1 trials), "1 drop of 0.5 % timolol maleate" (1 trials), "1 drop of 0.750% SYL040012 (bamosiran)" (1 trials) and "1 drop of 1.125% SYL040012 (bamosiran)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Torrevieja" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Torrevieja". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hospital de Torrevieja, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Torrevieja, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".